SCM
INBX

Sio Capital Management’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Sio Capital Management’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-365,210
Closed -$4.14M – 69
2022
Q2 		$4.14M Buy
365,210
+240,960
+194% +$3.54M 1.56% 21
2022
Q1 		$2.77M Buy
+124,250
New +$3.17M 0.92% 29

Other funds holding INBX

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Sio Capital Management's INBX Position: Q3 2022 in Review

Sio Capital Management sold out of Inhibrx, Inc. Common Stock (INBX) in Q3 2022, closing a stake of 365,210 shares — an estimated $4.14M sold.

Sio Capital Management first reported a position in INBX in Q1 2022 and held it in 2 quarters. The position peaked at $4.14M in Q2 2022. 102 funds tracked by Wall St. Rank hold INBX as of Q3 2022.

  • Sio Capital Management reported no remaining Inhibrx, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Sio Capital Management sold 365,210 Inhibrx, Inc. Common Stock shares in Q3 2022, an estimated $4.14M.
  • Sio Capital Management first reported a position in Inhibrx, Inc. Common Stock in Q1 2022 and held it in 2 quarters.
  • Sio Capital Management's Inhibrx, Inc. Common Stock position peaked at $4.14M in Q2 2022.
  • 102 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q3 2022.

Based on Sio Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.